The place of the third generation sulfonylurea glimepiride in modern therapy of type 2 diabetes mellitus
DOI:
https://doi.org/10.22141/2224-0721.15.2.2019.166106Keywords:
type 2 diabetes mellitus, sulfonylureas derivatives, glimepirideAbstract
The article considers the pharmacological and clinical aspects of the use of glimepiride, a third generation sulfonylurea, in modern therapy of type 2 diabetes mellitus. The drug is characterized by proven efficacy and safety, economical affordability, a number of favorable non-pancreatic effects, including cardioprotective properties. Everything mentioned above allows us to recommend it confidently for the treatment of type 2 diabetes mellitus.Downloads
References
Dovidnyk osnovnyh pokaznykiv dijal'nosti endokrynologichnoi' sluzhby Ukrai'ny za 2016 rik [A reference book of basic performance of endocrinology care of Ukraine indicators 2016]. Кyiv; 2017. 40 p. (in Ukrainian).
World Health Organization. Global report on diabetes. 2016. Available from: https://www.who.int/diabetes/global-report/en/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 L.V. Zhuravlyova, M.V. Filonenko
This work is licensed under a Creative Commons Attribution 4.0 International License.